Eton Pharmaceutcials, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ETON, updated each market day.
ETON AI Sentiment
AI sees no strong directional signal for Eton Pharmaceutcials, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Eton Pharmaceutcials, Inc. Common Stock
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Sector
Exchange
Market Cap
$626,724,758
Cap Tier
Employees
44
Headquarters
DEER PARK, IL
Listed Since
Nov. 14, 2018
Website
ETON Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ETON Volatility
Eton Pharmaceutcials, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
